Do you want to read an article? Please log in or register.
Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source: NAVIGATE-ESUS Trial
Stroke
Related content
Stroke
Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial
Stroke.
Ntaios G, Pearce LA, Meseguer E, Endres M, Amarenco P, Ozturk S, Lang W, Bornstein NM, Molina CA, Pagola J, Mundl H, Berkowitz SD, Liu YY, Sen S, Connolly SJ, Hart RG, NAVIGATE ESUS Investigators.
doi: 10.1161/STROKEAHA.
RECOMMENDED
Stroke
Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
doi: 10.1161/STROKEAHA.119.028669.
RECOMMENDED
Stroke
Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis
Stroke.
Ntaios G, Swaminathan B, Berkowitz SD, Gagliardi RJ, Lang W, Siegler JE, Lavados P, Mundl H, Bornstein N, Meseguer E, Amarenco P, Cucchiara B, Camps-Renom P, Makaritsis K, Korompoki E, Papavasileiou V, Marti-Fabregas J, Milionis H, Vemmos K, Connolly SJ, Hart RG, NAVIGATE ESUS Investigators.
doi: 10.1161/
Stroke
Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets: S2TOP-BLEED
Neurology.
Hilkens NA, Algra A, Diener HC, Reitsma JB, Bath PM, Csiba L, Hacke W, Kappelle LJ, Koudstaal PJ, Leys D, Mas JL, Sacco RL, Amarenco P, Sissani L, Greving JP; Cerebrovascular Antiplatelet Trialists' Collaborative Group
doi: 10.1212/
RECOMMENDED
Stroke
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
doi: 10.1161/STROKEAHA.119.028643.
RECOMMENDED
Stroke
Tailoring the Approach to Embolic Stroke of Undetermined Source: A Review
JAMA Neurol.
Kamel H, Merkler AE, Iadecola C, Gupta A, Navi BB
doi: 10.1001/jamaneurol.
Stroke
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials
Stroke
Bhatia K, Jain V, Aggarwal D, Vaduganathan M, Arora S, Hussain Z, Uberoi G, Tafur A, Zhang C, Ricciardi M, Qamar A
doi: 10.1161/STROKEAHA.120.033033
Stroke
Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention: A Systematic Review for the 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Stroke
Brown DL, Levine DA, Albright K, Kapral MK, Leung LY, Reeves MJ, Sico J, Strong B, Whiteley WN, American Heart Association Stroke Council.
doi: 10.1161/STR.0000000000000377
StrokeDementia
Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack
Cochrane Database Syst Rev.
Zonneveld TP, Richard E, Vergouwen MD, Nederkoorn PJ, de Haan R, Roos YB, Kruyt ND
doi: 10.1002/